# Single Center Registration Study on HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer

> **NCT06146114** · — · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 100 (estimated)

## Conditions studied

- HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Collect HER2 expression in prostate cancer patients

## Key facts

- **NCT ID:** NCT06146114
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06146114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06146114, "Single Center Registration Study on HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06146114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*